U.S. Specialized REITs Stock News

iQIYI (IQ) has put its AI ambitions front and center with the Global AI Creator Challenge on its NadouPro platform, which is built around Alibaba's Wan3.0 model for professional-grade video production. Despite the AI Creator Challenge giving iQIYI fresh narrative momentum, the stock has been under pressure. The share price is down 50.3% year to date and the 1-year total shareholder return has declined 61.2%, while the 3-year and 5-year total shareholder returns are also sharply weaker. Spot...

What the new Lakeside Bluffs launch means for KB Home stock KB Home (KBH) just opened Lakeside Bluffs in Lake Stevens, Washington, a new ENERGY STAR focused townhome community that gives investors a fresh data point on the builder's product mix and regional footprint. Recent trading tells a different story to KB Home’s new project pipeline. The share price has fallen 16.5% over the past month and is down 17.4% year to date, while the 5 year total shareholder return of 24.0% shows that longer...

Cheesecake Factory (CAKE) drew fresh attention after issuing 2026 guidance that points to about US$4b in total revenue and an updated net income margin target of roughly 5.4%. Recent trading reflects that new guidance. Cheesecake Factory’s share price is up 25.0% over 90 days and 82.8% year to date, while the 1-year total shareholder return of 80.1% and 3-year total shareholder return above 2.5x suggest that momentum has been strong even after a softer 7-day and 30-day share price...

Nscale’s push for a US listing at up to a $35b valuation, backed by Nvidia and anchored by long-term AI data centre contracts, has put a fresh spotlight on who really supplies the plumbing for AI. Capital is suddenly hunting for the next critical picks and shovels. This article examines three US and UK stocks from the AI data centre and cloud theme that could be positively exposed to this news-driven shift. The three stocks covered below are just a small sample of this theme. The full screen...

Blue Bird (BLBD) is in focus after investors revisited the school bus maker's fundamentals, including average unit sales growth of 9.2% over two years and an increased free cash flow margin. Recent trading has cooled after a strong run, with Blue Bird's share price falling 18.3% over the past 90 days but still delivering a 29.2% year to date share price return and a 3 year total shareholder return of over 200%. This suggests earlier optimism has been tempered as investors reassess growth...

Invesco (NYSE: IVZ) has partnered with GMH Communities to buy student housing assets near Purdue University. The acquired properties sit close to Purdue's main campus in West Lafayette, Indiana, a large public university in the US. The transaction adds to Invesco Real Estate's student housing holdings as the firm builds out its alternative property portfolio. This Purdue student housing deal only captures one piece of what is changing for Invesco Real Estate today. Our analysis turns up 2...

Twist Bioscience has seen its share price move sharply in recent years, which puts the spotlight squarely on one question for investors who care about cash flows. Is the current valuation supported by what this business is expected to generate in actual dollars over time, or is the market getting ahead of itself? Over the past 3 years, Twist Bioscience has delivered a share price return of about 7x. This raises the stakes on whether its future cash flows can underpin that kind of move. The...

Watts Water Technologies has delivered a strong multi year share price run, so the recent pullback raises a simple question for you as an investor. Are the cash flows behind the business enough to support where the stock trades today? Over the past 5 years, the stock has gained 113.6%, which puts a lot of weight on whether its current cash generation can support that kind of market value. Recent record sales, alongside slipping operating margins, suggest future cash flow may depend less on...

United Rentals recently told investors that construction equipment rental demand has exceeded its own expectations, helped by a strong pipeline of large projects and continued momentum in specialty rentals, which supported a guidance increase in July despite higher diesel costs. Management also highlighted heavier use of technology and AI across operations and customer service, signaling a push to squeeze more productivity and service quality from the existing rental fleet rather than...

Iovance Biotherapeutics (IOVA) is back in focus after reporting record second quarter revenue near US$100 million with a 56% margin, along with wider access to its TIL platform and an expanding solid tumor pipeline. The strong quarterly update has arrived alongside a sharp rebound in Iovance Biotherapeutics’ share price, with a 7-day share price return of 19.19% and a 90-day move of 162.15%. This has contributed to a year-to-date share price return of 306.75% and a 1-year total shareholder...

Plug Power featured as a key technology provider in a multibillion dollar sustainable aviation fuel project in Uzbekistan and recently presented at the Midwest NDR conference, giving investors fresh detail on its operations and financing plans. The Uzbekistan project, which could use up to 2.4 GW of Plug Power GenEco PEM electrolyzers, highlights the company’s focus on large, capital intensive clean hydrogen deployments, alongside efforts to refresh GenDrive units and pursue asset...

Redwire (RDW) just delivered a strong jolt of information for investors, with Q2 revenue and EBITDA beating expectations and management lifting full year guidance as analysts reassessed the stock’s cash flow potential. That upbeat Q2 message is landing against a mixed tape for Redwire, with the share price down 7.01% over the last day and 25.16% lower across 90 days, yet still showing an 18.94% year to date share price gain and a 35.09% 1 year total shareholder return that may indicate...

Vera Therapeutics reported that TRUTAKNA met all prespecified endpoints in the final Phase III ORIGIN 3 trial in adults with primary IgA nephropathy, with kidney function data characterized as strong, a safety profile generally comparable to placebo, and plans to seek full FDA approval through a supplemental BLA in late 2026. The therapy’s self-administered weekly autoinjector format, combined with early commercial momentum from more than 350 patient start forms, points to an execution focus...

Telephone and Data Systems (TDS) has been drawing fresh attention after recent trading left the stock around $35.90, with returns mixed across the past week, month, and past 3 months. Over the past year, the Telephone and Data Systems share price has moved through a mix of short bursts and pullbacks. The 30-day share price return of 3.55% contrasts with a year-to-date share price decline of 12.55%, while the 3-year total shareholder return of 107.61% and 5-year total shareholder return of...

Blackbaud shares have fallen back, with the stock closing at US$42.85 and posting a series of declines in recent periods. This puts fresh focus on whether that valuation is still supported by the company’s earnings power. After a run of negative returns, the key issue for investors is whether the current price properly reflects what the business is earning today. Over the past 5 years the share price has fallen 40.9%, which raises the question of whether the market is reassessing what...

Eli Lilly has turned into one of the most closely watched stocks in global healthcare, and with that attention comes a simple question for investors. At around US$1,152.93 per share, is the current price in line with the cash flows that Lilly can plausibly generate over time? Over the past 5 years, Eli Lilly has delivered a very large total return of about 4.2x, which puts a lot of weight on whether its cash flows can keep supporting such a re-rating. Recent approvals and upgrades around...

Archer Aviation has seen its share price fall sharply over the past year, which puts an uncomfortable spotlight on whether the current US$5.26 level still lines up with the value on its balance sheet. For anyone watching the electric air taxi space, the question now is how much of Archer Aviation's future story is already baked into a stock that has recently been heading lower. Over the past year the share price has declined 46.7%, which raises the question of whether the market is now...

Fortinet has seen its share price climb sharply in recent years, which puts fresh attention on whether the cash it is expected to generate really supports that kind of move. With the stock recently closing at US$169.84, the key issue is how that market value lines up against what the company's cash flows suggest it might be worth. Over the past 3 years, Fortinet has delivered a 191.6% share price return, which puts a lot of weight on the question of whether its cash generation can keep...

Growing concern over underwater cables and energy infrastructure security has pushed governments to rethink where critical materials come from. Rare earth miners sit right in that conversation because their output goes into advanced sensors, subsea monitoring gear, and defense systems. That link between security and supply is creating fresh attention on rare earth metal opportunities. This article highlights three rare earth stocks pulled from our specialist screener. The three rare earth...

Summit Therapeutics (SMMT) is back in focus after presenting updated Phase III HARMONi and HARMONi-2 data on ivonescimab at the IASLC World Conference on Lung Cancer, highlighting overall survival trends and safety consistency. Recent trading suggests momentum around Summit Therapeutics is building, with a 30-day share price return of 43.60% and a 90-day gain of 29.82%, while the 1-year total shareholder return is still down 5.51%. The very large 3-year total shareholder return hints at how...

Align Technology recently presented at the 2026 Global Healthcare Conference in New York, with CFO John F. Morici and IR lead Madelyn Valente outlining the company’s position after reporting quarterly earnings that exceeded expectations but came with lowered Q3 revenue guidance. The combination of better reported results and a more cautious revenue outlook highlights how inflation and postponed elective dental treatments remain a real drag on near term demand for Align’s clear aligners and...

Joby Aviation reported that its J208 aircraft, a converted Cessna Caravan, completed a 3,199 mile, fully autonomous U.S. cross country flight under remote supervision, handling taxi, takeoff, routing, and landings across varied airports and weather conditions. The cross country tour shows how Joby can apply its autonomy stack to already certified airframes for freight, medical logistics, disaster response, and defense work, which directly links expensive R&D to potential real world contracts...

Interest rates are climbing again, inflation is stubborn, and headline stock indexes have been restless since mid August, which puts steady cash returns back in the spotlight for many investors. Reliable dividends can feel like solid ground when borrowing costs rise and growth stories come under pressure. This article walks through 3 dividend-focused stocks exposed to these macro shifts and explains how each one could factor into your portfolio decisions now. The stocks highlighted below are...

Union Pacific executives recently outlined volume trends, fuel cost pressures, and network investment priorities at Morgan Stanley's Laguna Conference, while the Big Boy No. 4014 holiday tour supports Make-A-Wish through the Community Ties Giving Program. The focus on high-growth freight segments like renewable fuels and automotive gives investors a clearer view of where Union Pacific is targeting future volume opportunities. We will now see how Union Pacific's focus on high-growth freight...